OMC
PEARW

Old Mission Capital’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Old Mission Capital’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,563
Closed -$3K – 1846
2022
Q3 		$3K Buy
+17,563
New +$2.58K ﹤0.01% 894

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Old Mission Capital's PEARW Position: Q4 2022 in Review

Old Mission Capital sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q4 2022, closing a stake of 17,563 shares — an estimated $3K sold.

Old Mission Capital first reported a position in PEARW in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 33 funds tracked by Wall St. Rank hold PEARW as of Q4 2022.

  • Old Mission Capital reported no remaining Pear Therapeutics, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
  • Old Mission Capital sold 17,563 Pear Therapeutics, Inc. Warrant shares in Q4 2022, an estimated $3K.
  • Old Mission Capital first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2022 and held it in 1 quarter.
  • Old Mission Capital's Pear Therapeutics, Inc. Warrant position peaked at $3K in Q3 2022.
  • 33 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q4 2022.

Based on Old Mission Capital's 13F filing for Q4 2022, filed 14 Feb 2023.